ClinicalTrials.Veeva

Menu
V

Via Libre | Lima, Peru

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Islatravir
nucleoside
ISL
MK-8591
Lenacapavir
Apricitabine
Doravirine

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 11 total trials

Study of Lenacapavir for HIV Pre-Exposure Prophylaxis in People Who Are at Risk for HIV Infection (PURPOSE 2)

The goal of this clinical study is to test how well the study drug, lenacapavir (LEN), works in preventing the risk of HIV.

Active, not recruiting
Pre-Exposure Prophylaxis of HIV Infection
Drug: PTM F/TDF
Drug: Placebo SC LEN

Trial sponsors

Merck Sharp & Dohme (MSD) logo
A
Fred Hutchinson Cancer Center (FHCC) logo
Gilead Sciences logo
National Institute of Allergy and Infectious Diseases (NIAID) logo
University of Minnesota (UMN) logo
K
N
U

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems